METTL3 peptide inhibitors

METTL3 peptide inhibitor · Xijing Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for METTL3 peptide inhibitors, covering 2025-01-08 to 2025-01-08. Get the full timeline:

Most recent: Clinical Trial Update: Study on the Efficacy and Mechanism of METTL3 Peptide Inhibitors in Enhancing Anti-tumor Immune Response by Reshaping the Tumor Microenvironment

See pricing